RMM Grants Awarded

See where grants have been awarded across Minnesota.
Jason Doles, PhD
Neuromuscular diseases (NMDs) are life-altering conditions typically resulting in disability, poor quality of life, and eventual long-term dependency…
2021-2023
Sanjay Mirsa, MD
In the US, ~726,000 patients have end-stage renal disease (ESRD) requiring chronic hemodialysis, which will double in the coming decade. Optimal…
2021-2023
Atta Behfar, MD, PhD
1. Deployment of scalable and affordable regenerative solutions for patients who have experienced heart attack. 2. Establishment of safety for a…
2021-2023
Timothy O'Brien, DVM, PhD
We have developed a technically simple, scalable, cGMP‐compatible method to generate hyaline cartilage from human induced pluripotent stem cells.…
2020-2021
Wesley Wierson, PhD
LEAH Labs is bringing regenerative immunotherapy to dogs. We use gene editing to enable the translation of cell therapies from successful…
2020-2021
Dave Roeser
We have seven specific milestones with the goal of making bone morphogenetic protein and fibronectin (used to promote bone repair) that is…
2020-2021
Timothy O'Brien, DVM, PhD
We have developed a technically simple, scalable, cGMP‐compatible method to generate hyaline cartilage from human induced pluripotent stem cells.…
2020-2021
Amir Naqwi, PhD
We are proposing the development of an airway cell sprayer that would be included in the instrument channel of a bronchoscope for depositing viable…
2020-2021
Maria Athanasiou, PhD
Building on successful primate model studies, MarPam Pharma is developing a one‐time treatment for durable remission of HIV in the absence of…
2020-2021
Zeeshan Syedain, PhD
The goal of this translational research project is to generate preclinical data and demonstrate regenerative engineered tissue as a superior tissue…
2020-2022
Steven Moran, MD
The main goal of the project is to develop a therapeutic strategy for the regeneration of muscle volume and recovery of function after traumatic…
2020-2022
Brian Fife, PhD
Autoimmune or Type 1 diabetes (T1D) results from the immune‐mediated destruction of insulin producing beta cells in the pancreas islets. In this…
2020-2022